Therapeutic Drug Monitoring (TDM)

"Our therapeutic drug monitoring proficiency testing scheme - helping your lab to meet measurement challenges"

Therapeutic Drug Monitoring consists of the measurement of specific drug concentrations at timed intervals in patients, usually through blood/serum samples, and is necessary where control of drug concentrations is required to achieve optimum treatment for the patient, or where there is a narrow range between the therapeutic and toxic levels.

TDM, AXIO's Therapeutic Drugs Monitoring proficiency testing programme, provides independent performance assessment for labs undertaking the routine quantification of a wide range of anti-epileptic and other therapeutic drugs.

The operation of the TDM scheme is supported by an Advisory Group consisting of members of professional bodies, scheme participants, and others experienced in the field. The scheme reports on the performance of UK participants (who have clinical responsibilities) to the National Quality Assurance Advisory Panels for Chemical Pathology.